BRT with MEBT/MEBO preserves the surviving tissue to the greatest extent currently possible.

Burns wound surface is not smooth and a surgical knife cannot distinguish between injured tissue and surviving tissue.

Surgeons always excise the surviving tissue together with dead tissue and this is a very serious attack on the patient – at times it can be more serious than burns injury itself. 

Moreover, after excision, the body surface typically never recovers the loss of subcutaneous surviving tissue. 

However, studies demonstrate that, if not excised, this recovery can occur.

BRT with MEBT/MEBO takes advantage of the frame structure of the nutritive base of the drug and the principle of biochemistry therewith successfully preserving the surviving tissue.